IRIS Accounts Production v25.1.4.42 NI690819 director 1.10.23 30.9.24 30.9.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhNI6908192023-09-30NI6908192024-09-30NI6908192023-10-012024-09-30NI6908192022-08-31NI6908192022-09-012023-09-30NI6908192023-09-30NI690819ns15:NorthernIreland2023-10-012024-09-30NI690819ns14:PoundSterling2023-10-012024-09-30NI690819ns10:Director12023-10-012024-09-30NI690819ns10:PrivateLimitedCompanyLtd2023-10-012024-09-30NI690819ns10:SmallEntities2023-10-012024-09-30NI690819ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-30NI690819ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-30NI690819ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-30NI690819ns10:FullAccounts2023-10-012024-09-30NI690819ns10:RegisteredOffice2023-10-012024-09-30NI690819ns5:CurrentFinancialInstruments2024-09-30NI690819ns5:CurrentFinancialInstruments2023-09-30NI690819ns5:ShareCapital2024-09-30NI690819ns5:ShareCapital2023-09-30NI690819ns5:RetainedEarningsAccumulatedLosses2024-09-30NI690819ns5:RetainedEarningsAccumulatedLosses2023-09-30NI690819ns5:FurnitureFittings2023-10-012024-09-30NI690819ns5:ComputerEquipment2023-10-012024-09-30NI690819ns5:FurnitureFittings2023-09-30NI690819ns5:ComputerEquipment2023-09-30NI690819ns5:FurnitureFittings2024-09-30NI690819ns5:ComputerEquipment2024-09-30NI690819ns5:FurnitureFittings2023-09-30NI690819ns5:ComputerEquipment2023-09-30NI690819ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-30NI690819ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-30NI6908191ns10:Director12023-09-30NI6908191ns10:Director12022-08-31NI6908191ns10:Director12023-10-012024-09-30NI6908191ns10:Director12022-09-012023-09-30NI6908191ns10:Director12024-09-30NI6908191ns10:Director12023-09-30
REGISTERED NUMBER: NI690819 (Northern Ireland)









WJ MEDICAL LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2024






WJ MEDICAL LIMITED (REGISTERED NUMBER: NI690819)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


WJ MEDICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2024







DIRECTOR: Dr W Jia





REGISTERED OFFICE: Apartment 39
2 Pilot Place
Belfast
Northern Ireland
BT1 3AG





REGISTERED NUMBER: NI690819 (Northern Ireland)





ACCOUNTANTS: Morris Crocker
Chartered Accountants
Station House
North Street
Havant
Hampshire
PO9 1QU

WJ MEDICAL LIMITED (REGISTERED NUMBER: NI690819)

BALANCE SHEET
30 SEPTEMBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,291 1,018

CURRENT ASSETS
Debtors 5 2,149 -
Cash at bank 95,006 36,012
97,155 36,012
CREDITORS
Amounts falling due within one year 6 15,649 8,009
NET CURRENT ASSETS 81,506 28,003
TOTAL ASSETS LESS CURRENT
LIABILITIES

82,797

29,021

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 82,796 29,020
SHAREHOLDERS' FUNDS 82,797 29,021

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 27 June 2025 and were signed by:





Dr W Jia - Director


WJ MEDICAL LIMITED (REGISTERED NUMBER: NI690819)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

1. STATUTORY INFORMATION

WJ Medical Limited is a private company, limited by shares , registered in Northern Ireland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on cost
Computer equipment - 33% on cost

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties and loans to related parties and investments in non-puttable ordinary shares.

Trade and other debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment

Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, deposits with banks and other short-term highly liquid investments and bank overdrafts. In the balance sheet, bank overdrafts are shown within borrowings or current liabilities.

Trade and other creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


WJ MEDICAL LIMITED (REGISTERED NUMBER: NI690819)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 October 2023 1,357 - 1,357
Additions - 919 919
At 30 September 2024 1,357 919 2,276
DEPRECIATION
At 1 October 2023 339 - 339
Charge for year 340 306 646
At 30 September 2024 679 306 985
NET BOOK VALUE
At 30 September 2024 678 613 1,291
At 30 September 2023 1,018 - 1,018

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other debtors 2,149 -

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Taxation and social security 14,538 7,038
Other creditors 1,111 971
15,649 8,009

WJ MEDICAL LIMITED (REGISTERED NUMBER: NI690819)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024

7. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the year ended 30 September 2024 and the period ended 30 September 2023:

2024 2023
£    £   
Dr W Jia
Balance outstanding at start of year - -
Amounts advanced 2,149 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 2,149 -